Preconditioning of Umbilical Cord-derived Mesenchymal Stem Cells by Rapamycin Increases Cell Migration and Ameliorates Liver Ischaemia/reperfusion Injury in Mice Via the CXCR4/CXCL12 Axis
Overview
Authors
Affiliations
Objectives: Transfusion of umbilical cord-derived mesenchymal stem cells (UC-MSCs) is a novel strategy for treatment of various liver diseases. However, the therapeutic effect of UC-MSCs is limited because only a few UC-MSCs migrate towards the damaged regions. In this study, we observed the effects of autophagy on the migration of UC-MSCs in vitro and in a model of liver ischaemia/reperfusion (I/R) injury.
Materials And Methods: We investigated the effects of autophagy on the status of the cell, release of anti-inflammatory factors and migration of UC-MSCs in vitro. The therapeutic effects and in vivo migration of rapamycin-preconditioned UC-MSCs were observed in a C57/B6 mouse model of liver I/R injury.
Results: Induction of autophagy by rapamycin enhanced the ability of UC-MSCs to migrate and release anti-inflammatory cytokines as well as increased expression of CXCR4 without affecting cell viability. Inhibition of CXCR4 activation markedly decreased migration of these cells. In a mouse model of liver I/R injury, we found significantly upregulated expression of CXCR12 in the damaged liver. More rapamycin-preconditioned UC-MSCs migrated towards the ischaemic regions than 3-methyladenine-preconditioned or non-preconditioned UC-MSCs, leading to improvement in hepatic performance, pathological changes and levels of inflammatory cytokines. These effects were abolished by AMD3100.
Conclusions: Preconditioning of UC-MSCs by rapamycin afforded increased protection against liver I/R injury by enhancing immunosuppression and strengthening the homing and migratory capacity of these cells via the CXCR4/CXCL12 axis.
Yu S, Wang Y, Shi Y, Yu S, Zhao B, Liao N Bioeng Transl Med. 2025; 10(2):e10735.
PMID: 40060764 PMC: 11883125. DOI: 10.1002/btm2.10735.
Zhang J, Qiu X, Lei Y, Chen H, Wu D, Wang T Exp Mol Med. 2025; .
PMID: 40025174 DOI: 10.1038/s12276-025-01413-4.
Gong Y, You Q, Yuan X, Zeng F, Zhang F, Xiao J Redox Biol. 2025; 81:103556.
PMID: 39986119 PMC: 11893313. DOI: 10.1016/j.redox.2025.103556.
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.
Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.
PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.
Alizadeh S, Jahani S, Rezaei Zadeh Rukerd M, Tabrizi R, Masoomi R, Banihashemian S Stem Cell Res Ther. 2024; 15(1):442.
PMID: 39563393 PMC: 11577959. DOI: 10.1186/s13287-024-04033-3.